Negative-pressure Wound Therapy (NPWT) Segmentation
The negative-pressure wound therapy (NPWT) market is segmented and analyzed for demand and supply by application into burn wounds, surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, out of which, the diabetic foot ulcers segment is anticipated to significantly grow over the forecast period owing to the globally increasing prevalence of diabetic foot ulcers. For instance, the global annual incidence of diabetic foot ulcers ranges from 9 to 25 million.
Our in-depth analysis of the global market includes the following segments:
|
By Devices Type |
|
|
By Wound Type |
|
|
By Application |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of negative-pressure wound therapy is estimated at USD 2.88 billion.
Negative-pressure Wound Therapy (NPWT) Market size was valued at USD 2.73 billion in 2024 and is likely to cross USD 6.19 billion by 2037, registering more than 6.5% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to hold largest revenue share by 2037, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region.
The major players in the market are Smith & Nephew, PLC, Acelity L.P., Inc., Cardinal Health, DeRoyal Industries Inc., Genadyne Biotechnologies, Inc., Medela, LLC., ConvaTec, Inc., ATMOS MedizinTechnik, GmbH & Co. KG, and others.
